Article: PARP inhibition in BRCA-mutated ovarian cancer

Related products

• 

  Article: Highlights in digestive oncology

  €2.42 Add to cart
• 

  Article: Highlights in urologic cancer

  €2.42 Add to cart
• 

  Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma

  €2.42 Add to cart
• 

  Article: Highlights in breast cancer

  €2.42 Add to cart